lead position
Sponsored content
Sponsored by
Zacco
Features list
-
Using IP as security is an attractive way of accessing finance for many companies. Alexandra Pygall and Mark Kramer explain the issues borrowers and lenders need to consider
-
US copyright law is in flux. Margaret A Esquenet, John F Hornick and Brian R Westley review recent and pending cases, and also look at the impact of 3D printing and possible legislative changes
-
A recent decision in the US may encourage patent owners who assign or license their rights to others for enforcement. Max Grant and Kieran Dickinson examine the implications for those structuring privateering deals and those challenging them
-
As the US intensifies efforts to rein in patent trolls, the CEOs of some of America’s biggest patent monetisation firms say they support measures designed to deter abuse of the patent system, if the actions apply industry-wide. David Hatch reports
-
Rafael Marques Rocha and André Ferreira de Oliveira of Daniel Advogados give an overview of court decisions covering patent prosecution in Brazil in the last decade
-
The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling
Local Insights